Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignant and nonmalignant conditions. pulmonary complications, infectious and noninfectious, are a major cause of morbidity and mortality in these patients. the recent advances in prophylaxis and treatment of infectious complications increased the significance of noninfectious pulmonary conditions. acute lung injury due to diffuse alveolar hemorrhage or idiopathic pneumonia syndrome are the main acute complications, while bronchiolitis obliterans remains the most challenging pulmonary complications facing clinicians who are taking care of HSCT recipients. there are other noninfectious pulmonary complications following HSCT that are less frequent. th...
SummaryBackgroundVarious late-onset noninfectious pulmonary complications may occur after allogeneic...
AbstractPulmonary hypertension (PH) is a potentially fatal complication of hematopoietic stem cell t...
AbstractEngraftment syndrome (ES) encompasses a constellation of symptoms that occur during neutroph...
Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignan...
Noninfectious pulmonary complications of hematopoietic stem cell transplant are currently more preva...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Effect on survival of the development of late-onset non-infectious pulmonary complications after ste...
AbstractPulmonary complications are important cause of mortality and morbidity after hematopoietic s...
Pediatric data about early or long-term pulmonary complications of hematopoietic stem cell transplan...
Nonmyeloablative conditioning before allogeneic hematopoietic cell transplant (HCT) is an alternativ...
Of 50,000 to 60,000 hematopoietic stem cell trans-plants (HSCTs) performed annually, 35,000 to 40,00...
WOS: 000288784700022PubMed ID: 21403586Background. Late-onset noninfectious pulmonary complications ...
Donor lymphocyte infusion (DLI) is a therapeutic modality for relapsed hematological malignancies af...
12We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmon...
SummaryBackgroundVarious late-onset noninfectious pulmonary complications may occur after allogeneic...
AbstractPulmonary hypertension (PH) is a potentially fatal complication of hematopoietic stem cell t...
AbstractEngraftment syndrome (ES) encompasses a constellation of symptoms that occur during neutroph...
Hematopoietic stem cell transplantation (HSCT) is an established treatment for a variety of malignan...
Noninfectious pulmonary complications of hematopoietic stem cell transplant are currently more preva...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Hematopoietic stem cell transplants (HSCT) are becoming more widespread as a result of optimization ...
Effect on survival of the development of late-onset non-infectious pulmonary complications after ste...
AbstractPulmonary complications are important cause of mortality and morbidity after hematopoietic s...
Pediatric data about early or long-term pulmonary complications of hematopoietic stem cell transplan...
Nonmyeloablative conditioning before allogeneic hematopoietic cell transplant (HCT) is an alternativ...
Of 50,000 to 60,000 hematopoietic stem cell trans-plants (HSCTs) performed annually, 35,000 to 40,00...
WOS: 000288784700022PubMed ID: 21403586Background. Late-onset noninfectious pulmonary complications ...
Donor lymphocyte infusion (DLI) is a therapeutic modality for relapsed hematological malignancies af...
12We evaluated the incidence, risk factors, and clinical outcome of late-onset non-infectious pulmon...
SummaryBackgroundVarious late-onset noninfectious pulmonary complications may occur after allogeneic...
AbstractPulmonary hypertension (PH) is a potentially fatal complication of hematopoietic stem cell t...
AbstractEngraftment syndrome (ES) encompasses a constellation of symptoms that occur during neutroph...